Last reviewed · How we verify
NCT07030582
Efficacy of Internet-Based Cognitive Behavioral Therapy for Back Muscle Strength Loss, Chronic Pain, and Poor Patient Recovery Perceptions After Lumbar Fusion
NA trial testing Internet-delivered cognitive behavioral therapy in Internet-Based Cognitive Behavioral Therapy in 100 participants. Currently enrolling.
31 July 2027
Quick facts
| Lead sponsor | Jiawei Jiang |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 December 2023 |
| Primary completion | 31 July 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Internet-delivered cognitive behavioral therapy
- Basic Postoperative Care
- Conventional Postoperative Care
Conditions studied
- Internet-Based Cognitive Behavioral Therapy — all drugs for Internet-Based Cognitive Behavioral Therapy →
Sponsor
Jiawei Jiang
Who can join
Adults 18 to 55, any sex, with Internet-Based Cognitive Behavioral Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to develop an Internet-based Cognitive Behavioral Therapy protocol for core muscle training, based on an understanding of factors impeding postoperative core muscle training in lumbar surgery patients. The protocol is designed to reconstruct patients' cognition, eliminate adverse behaviors, and promote healthy behaviors such as core muscle training among LDH patients. The ultimate objectives are to alleviate postoperative pain, enhance lumbar stability, and facilitate disease rehabilitation in patients following lumbar surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of internet-based cognitive behavioral therapy on kinesiophobia, exercise adherence, and back muscle function after lumbar fusion surgery.
Wang T, Jiang J, Li C, Xuan Q, et al · · 2026 · PMID 41845320 · DOI 10.1186/s12891-026-09617-z
Verify or expand the search:
- PubMed search for NCT07030582
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07030582 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jiawei Jiang
- Last refreshed: 22 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07030582.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing